Cationic Amino Acid Transporter-1-Mediated Arginine Uptake Is Essential for Chronic Lymphocytic Leukemia Cell

Anke Werner1,2, Daniel Pieh2, Hakim Echchannaoui1

  • 1Third Department of Medicine (Hematology, Oncology, and Pneumology), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.

Frontiers in Oncology
|December 12, 2019
PubMed

Insights

Chronic lymphocytic leukemia (CLL) cells require extracellular arginine for growth and lack its endogenous synthesis. Inhibiting the arginine transporter CAT-1 halts proliferation and tumor growth, offering a potential new therapy for CLL.

Area of Science:

  • Oncology
  • Cancer Metabolism
  • Amino Acid Transport

Background:

  • Tumor cells often rely on external nutrients, including arginine, due to impaired endogenous synthesis.
  • Chronic lymphocytic leukemia (CLL) cells are identified as arginine-auxotrophic, lacking argininosuccinate synthase (ASS).
  • Arginine uptake in mammalian cells is facilitated by solute carrier (SLC) family transporters.

Purpose of the Study:

  • To investigate the dependence of chronic lymphocytic leukemia (CLL) cells on extracellular arginine.
  • To identify the specific arginine transporter(s) utilized by CLL cells.
  • To evaluate the therapeutic potential of targeting arginine transport in CLL.

Main Methods:

  • Assessed arginine dependence and ASS expression in primary and immortalized CLL cells.
  • Utilized lentiviral-mediated gene downregulation to inhibit the cationic amino acid transporter-1 (CAT-1) in HG3 CLL cells.
  • Evaluated the impact of CAT-1 inhibition on arginine uptake, proliferation, viability, and tumor growth in a murine xenograft model.

Main Results:

  • CLL cells were confirmed to be arginine-auxotrophic, expressing only CAT-1 for arginine import.
  • Downregulation of CAT-1 significantly reduced arginine uptake, proliferation, and viability of HG3 CLL cells.
  • In vivo, CAT-1 inhibition in CLL cells led to significant suppression of tumor growth in a murine model.

Conclusions:

  • Targeting extracellular arginine availability is a viable strategy for cancer therapy.
  • CAT-1 is the primary arginine importer in CLL cells and a critical dependency.
  • Inhibition of CAT-1 presents a promising therapeutic approach for treating chronic lymphocytic leukemia.

Related Concept Videos

ABC Transporters: Exporter01:31

ABC Transporters: Exporter

ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
6.2K
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
936
ABC Transporters: Importer01:27

ABC Transporters: Importer

ATP-binding cassette or ABC transporters are a class of ATP-driven pumps that hydrolyze ATP to move solutes across the membrane. They can be grouped into importers and exporters. While exporters are present in all domains of life, importers exist only in bacteria and some plants.
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
3.3K
Active Transport01:14

Active Transport

Active transport is a critical biological process that allows cells to move solutes against an electrochemical gradient. This process requires direct energy input and is characterized by its selectivity, saturability, and susceptibility to competitive inhibition.
Primary active transporters, like Na+, K+ and -ATPase, directly utilize ATP to move ions across the membrane. These transporters play significant roles in various physiological processes. For instance, Na+, K+ and -ATPase maintain...
1.9K
Amino Acid Biosynthetic Pathways01:29

Amino Acid Biosynthetic Pathways

Amino acid biosynthesis is essential for cell growth, protein synthesis, and metabolic regulation. Cells generate essential and non-essential amino acids from metabolic intermediates to sustain vital biological functions. These intermediates originate from key metabolic pathways: glycolysis, the tricarboxylic acid (TCA) cycle, and the pentose phosphate pathway. Important precursors include α-ketoglutarate, pyruvate, oxaloacetate, phosphoenolpyruvate, and erythrose-4-phosphate, which...
864
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
3.6K